Moderna (MRNA) Guides FY23 Covid-19 Vax Revenue of $6B-$8B
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Wall St set for higher open as SpaceX, Super Micro results rekindle AI trade
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- AI bubble about to burst? Not yet, Yardeni says
- SpaceX tops Q3 estimates as revenue surges 161% on Starlink, AI compute expansion
Tweet
Share
E-mail
Get Alerts MRNA Hot Sheet
Join SI Premium – FREE
Moderna (MRNA) Guides FY23 Covid-19 Vax Revenue of $6B-$8B
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Moderna (MRNA) PT Raised to $90 at TD Cowen
- Teledyne Technologies (TDY) Tops Q3 EPS by 56c, Beats on Revenue; Offers FY26 EPS Guidance
- Moody's Corp. (MCO) Misses Q3 EPS by 11c; offers guidance
Create E-mail Alert Related Categories
Guidance, Hot Guidance, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
